MERTK and retinitis pigmentosa: Identifying the primary and secondary cell types and stimulus mechanism for such inflammatory pathways will be a subject of future studies and may identify cellular molecular targets for therapies aiming to delay onset of the aggressive forms of retinitis pigmentosa associated with defective MerTK.